Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia
Clinical trial NCT00856973 · COMPLETED
Trial details
- NCT number
- NCT00856973
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-05-01
- Primary completion
- 2011-07-01
- Enrollment
- 486
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.